Tianjin, China

Hao Chen

This inventor holds 2 USPTO granted patents. Top assignee: Apotex Pharmachem Inc.. Active years: 2011-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hao Chen. Retrieved from https://idiyas.com/inventor/hao-chen-m5ww9wuo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2011-2013

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Hao Chen in Pharmaceutical Chemistry

Introduction

Hao Chen is a notable inventor based in Tianjin, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of processes for synthesizing important compounds. With a total of 2 patents to his name, his work has implications for the production of vital medications.

Latest Patents

Hao Chen's latest patents focus on the methods of making Efavirenz and its intermediates. The first patent outlines a process for the preparation of Efavirenz, where a compound of Formula 1 can be synthesized by cyclizing a compound of Formula 5 with a haloformate of Formula 6 in the presence of a first base. This innovative approach not only streamlines the production process but also introduces novel compounds that can be utilized in these methods.

Career Highlights

Hao Chen is currently employed at Apotex Pharmachem Inc., where he continues to advance his research in pharmaceutical processes. His expertise in synthetic methods has positioned him as a valuable asset in the industry, contributing to the development of effective treatments.

Collaborations

Hao Chen has collaborated with several talented individuals in his field, including Bo Chen and Zhi-Xian Wang. These partnerships have fostered a collaborative environment that enhances innovation and the sharing of ideas.

Conclusion

Hao Chen's contributions to pharmaceutical chemistry, particularly through his patents on Efavirenz synthesis, highlight his role as an influential inventor. His work not only advances scientific knowledge but also has the potential to improve healthcare outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…